Compare Marathon Petroleum Corp (MPC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marathon Petroleum Corp vs Zoetis Inc — how do they compare? Marathon Petroleum Corp trades at $319.23 (market cap $92.05B), while Zoetis Inc trades at $75.47 (market cap $31.95B). The key difference: Marathon Petroleum Corp is far larger — about 2.9× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| MPC | ZTS | |
|---|---|---|
Market Cap | $92.05B | $31.95B |
Sector | Energy | Health |
52-Week High | $315.31 | $156.76 |
52-Week Low | $158.59 | $71.91 |
Enterprise Value | $124.23B | $39.24B |
Dividend Yield | 1.24% | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marathon Petroleum (MPC) trades at $319.76, up 2.29% with strong technical momentum and bullish moving average signals. The stock shows robust fundamentals with a 27.92% ROE and 3.42% net margin, though revenue has declined from $177.5B in 2022 to $132.7B in 2025. Recent earnings beat expectations in Q4 2025 and Q1 2026, while analyst consensus remains strongly bullish with 25 buy ratings and a $292.70 price target. The company benefits from strong refining margins and strategic upgrades driving profitability.
MPC presents a compelling investment case with strong profitability metrics and positive analyst sentiment, though investors should monitor declining revenue trends and elevated debt levels. The stock's current price near resistance levels suggests potential for consolidation, while refining margin advantages and limited Russian capacity create tailwinds. Key risks include oil price volatility and macroeconomic pressures on energy demand.
Zoetis (ZTS) trades at $75.33, down 1.61% amid mixed technical signals and ongoing securities litigation. The stock shows strong fundamentals with a 28.03% net margin and 67.75% ROE, supported by consistent revenue growth from $8.1B in 2022 to $9.47B in 2025. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026, with Q2 results pending. Analyst consensus remains positive with a $101.43 price target, though technical indicators show neutral momentum near key support at $75.
The outlook for ZTS is cautiously optimistic given robust profitability and analyst support, but significant legal overhangs and recent earnings volatility present near-term risks. Long-term growth in animal health markets offers upside, yet investors should monitor litigation developments and Q2 earnings for directional cues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
